Novartis AG Receivables 2010-2024 | NVS

Novartis AG receivables for the quarter ending December 31, 2024 were $7.556B, a 0.31% increase year-over-year.

  • Novartis AG receivables for 2024 were $7.556B, a 0.31% increase from 2023.
  • Novartis AG receivables for 2023 were $7.533B, a 9.61% decline from 2022.
  • Novartis AG receivables for 2022 were $8.334B, a 0.62% increase from 2021.

Novartis AG Receivables 2010-2024 | NVS

  • Novartis AG receivables for 2024 were $7.556B, a 0.31% increase from 2023.
  • Novartis AG receivables for 2023 were $7.533B, a 9.61% decline from 2022.
  • Novartis AG receivables for 2022 were $8.334B, a 0.62% increase from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$823.1B
Johnson & Johnson (JNJ)$380.1B
Novo Nordisk (NVO)$374.3B
AbbVie (ABBV)$348.4B
Roche Holding AG (RHHBY)$259.5B
Merck (MRK)$216.5B
Pfizer (PFE)$146.7B
Sanofi (SNY)$136B
Bayer (BAYRY)$22B
Innoviva (INVA)$1.1B